vs
Side-by-side financial comparison of Silvercrest Asset Management Group Inc. (SAMG) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $28.1M, roughly 1.1× ARS Pharmaceuticals, Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -147.1%, a 146.8% gap on every dollar of revenue. On growth, Silvercrest Asset Management Group Inc. posted the faster year-over-year revenue change (-0.0% vs -67.6%).
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
SAMG vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.0M | $28.1M |
| Net Profit | $-120.0K | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | -2.8% | -147.6% |
| Net Margin | -0.4% | -147.1% |
| Revenue YoY | -0.0% | -67.6% |
| Net Profit YoY | -107.4% | -182.8% |
| EPS (diluted) | $0.02 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.0M | $28.1M | ||
| Q3 25 | $31.3M | $32.5M | ||
| Q2 25 | $30.7M | $15.7M | ||
| Q1 25 | $31.4M | $8.0M | ||
| Q4 24 | $32.0M | $86.6M | ||
| Q3 24 | $30.4M | $2.1M | ||
| Q2 24 | $31.0M | $500.0K | ||
| Q1 24 | $30.3M | $0 |
| Q4 25 | $-120.0K | $-41.3M | ||
| Q3 25 | $618.0K | $-51.2M | ||
| Q2 25 | $1.9M | $-44.9M | ||
| Q1 25 | $2.5M | $-33.9M | ||
| Q4 24 | $1.6M | $49.9M | ||
| Q3 24 | $2.3M | $-19.1M | ||
| Q2 24 | $2.7M | $-12.5M | ||
| Q1 24 | $3.0M | $-10.3M |
| Q4 25 | -2.8% | -147.6% | ||
| Q3 25 | 4.3% | -163.7% | ||
| Q2 25 | 13.2% | -302.9% | ||
| Q1 25 | 15.4% | -466.3% | ||
| Q4 24 | 6.1% | 54.5% | ||
| Q3 24 | 14.6% | -1051.6% | ||
| Q2 24 | 17.1% | -3068.0% | ||
| Q1 24 | 19.5% | — |
| Q4 25 | -0.4% | -147.1% | ||
| Q3 25 | 2.0% | -157.4% | ||
| Q2 25 | 6.3% | -285.6% | ||
| Q1 25 | 7.9% | -425.7% | ||
| Q4 24 | 5.1% | 57.7% | ||
| Q3 24 | 7.4% | -925.0% | ||
| Q2 24 | 8.6% | -2503.2% | ||
| Q1 24 | 9.9% | — |
| Q4 25 | $0.02 | $-0.41 | ||
| Q3 25 | $0.07 | $-0.52 | ||
| Q2 25 | $0.21 | $-0.46 | ||
| Q1 25 | $0.26 | $-0.35 | ||
| Q4 24 | $0.16 | $0.52 | ||
| Q3 24 | $0.24 | $-0.20 | ||
| Q2 24 | $0.28 | $-0.13 | ||
| Q1 24 | $0.32 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $44.1M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $50.3M | $114.3M |
| Total Assets | $166.6M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.1M | $245.0M | ||
| Q3 25 | $36.1M | $288.2M | ||
| Q2 25 | $30.0M | $240.1M | ||
| Q1 25 | $36.3M | $275.7M | ||
| Q4 24 | $68.6M | $314.0M | ||
| Q3 24 | $58.1M | $204.6M | ||
| Q2 24 | $49.9M | $218.7M | ||
| Q1 24 | $39.7M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $50.3M | $114.3M | ||
| Q3 25 | $58.9M | $147.7M | ||
| Q2 25 | $64.6M | $192.3M | ||
| Q1 25 | $80.0M | $229.0M | ||
| Q4 24 | $80.7M | $256.8M | ||
| Q3 24 | $84.6M | $201.0M | ||
| Q2 24 | $85.3M | $215.2M | ||
| Q1 24 | $83.9M | $223.9M |
| Q4 25 | $166.6M | $327.7M | ||
| Q3 25 | $157.6M | $372.8M | ||
| Q2 25 | $152.7M | $313.5M | ||
| Q1 25 | $159.9M | $327.3M | ||
| Q4 24 | $194.4M | $351.2M | ||
| Q3 24 | $184.2M | $217.6M | ||
| Q2 24 | $177.6M | $222.0M | ||
| Q1 24 | $170.2M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.6M | $-43.5M |
| Free Cash FlowOCF − Capex | $15.0M | — |
| FCF MarginFCF / Revenue | 46.9% | — |
| Capex IntensityCapex / Revenue | 11.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.6M | $-43.5M | ||
| Q3 25 | $14.6M | $-47.0M | ||
| Q2 25 | $13.8M | $-39.6M | ||
| Q1 25 | $-24.7M | $-40.7M | ||
| Q4 24 | $21.6M | $42.0M | ||
| Q3 24 | $13.3M | $-14.5M | ||
| Q2 24 | $16.0M | $-7.3M | ||
| Q1 24 | $-24.1M | $-6.7M |
| Q4 25 | $15.0M | — | ||
| Q3 25 | $13.8M | $-47.2M | ||
| Q2 25 | $13.4M | $-39.6M | ||
| Q1 25 | $-25.1M | $-40.8M | ||
| Q4 24 | $19.9M | $41.7M | ||
| Q3 24 | $12.9M | $-14.6M | ||
| Q2 24 | $15.6M | $-7.3M | ||
| Q1 24 | $-24.7M | $-6.8M |
| Q4 25 | 46.9% | — | ||
| Q3 25 | 44.1% | -145.4% | ||
| Q2 25 | 43.6% | -252.2% | ||
| Q1 25 | -80.0% | -512.1% | ||
| Q4 24 | 62.2% | 48.2% | ||
| Q3 24 | 42.4% | -706.3% | ||
| Q2 24 | 50.4% | -1463.4% | ||
| Q1 24 | -81.6% | — |
| Q4 25 | 11.4% | 0.0% | ||
| Q3 25 | 2.6% | 0.6% | ||
| Q2 25 | 1.5% | 0.3% | ||
| Q1 25 | 1.3% | 1.1% | ||
| Q4 24 | 5.3% | 0.3% | ||
| Q3 24 | 1.2% | 6.8% | ||
| Q2 24 | 1.1% | 7.6% | ||
| Q1 24 | 2.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 23.62× | — | ||
| Q2 25 | 7.22× | — | ||
| Q1 25 | -10.01× | — | ||
| Q4 24 | 13.34× | 0.84× | ||
| Q3 24 | 5.90× | — | ||
| Q2 24 | 6.00× | — | ||
| Q1 24 | -8.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
